Breaking News Instant updates and real-time market news.

CPRT

Copart

$58.30

-1.6 (-2.67%)

, DPS

Ticker changed to KDP

$121.99

-0.195 (-0.16%)

18:25
06/25/18
06/25
18:25
06/25/18
18:25

S&P announces changes to S&P 400, 500 indices

S&P MidCap 400 constituent Copart (CPRT) will replace Dr Pepper Snapple Group (DPS) in the S&P 500, and Exelixis (EXEL) will replace Copart in the S&P MidCap 400 effective prior to the open of trading on Monday, July 2. Dr Pepper Snapple Group, which is merging with privately held Keurig Green Mountain, is changing its name to Keurig Dr Pepper and its ticker symbol (KDP) in a transaction expected to be completed soon. The newly combined company will no longer be eligible for inclusion in the S&P 500 as its Investable Weight Factor, which measures the percentage of free float available to the public, is expected to fall well below the 50% eligibility threshold needed for continued inclusion in the index.

CPRT

Copart

$58.30

-1.6 (-2.67%)

DPS

Ticker changed to KDP

$121.99

-0.195 (-0.16%)

EXEL

Exelixis

$19.55

-0.52 (-2.59%)

  • 14

    Jan

CPRT Copart
$58.30

-1.6 (-2.67%)

03/23/18
03/23/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Eagle (AEO) initiated with a Buy at Loop Capital. 2. GoDaddy (GDDY) initiated with a Buy at Goldman Sachs while Wix.com (WIX) was initiated with a Neutral. 3. KAR Auction (KAR) and Copart (CPRT) were initiated with a Buy at SunTrust while Monro (MNRO) was initiated with a Hold. 4. Talend (TLND) initiated with a Buy at Needham. 5. Sun Hydraulics (SNHY) initiated with a Buy at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/23/18
RHCO
03/23/18
INITIATION
Target $58
RHCO
Buy
Copart initiated with a Buy at SunTrust
As reported earlier, SunTrust analyst Stephanie Benjamin initiated Copart with a Buy rating and a price target of $58. Benjamin cites the company's 40% market share, "above-peer margin profile", and consistent high single digit or more volume growth. The analyst expects Copart to continue executing amid favorable industry trends with rising revenue per unit and ongoing international expansion.
03/22/18
RHCO
03/22/18
INITIATION
Target $58
RHCO
Buy
Copart initiated with a Buy at SunTrust
SunTrust initiated Copart with a Buy and $58 price target.
05/18/18
SPHN
05/18/18
DOWNGRADE
Target $54
SPHN
Equal Weight
Copart downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Ben Beinvenu downgraded Copart to Neutral citing recent run in shares and maintained a $54 price target.
DPS Ticker changed to KDP
$121.99

-0.195 (-0.16%)

03/21/18
BMOC
03/21/18
NO CHANGE
Target $122
BMOC
Market Perform
Dr Pepper Snapple analyst day profiled rising coffee consumption, says BMO
BMO Capital analyst Amit Sharma keeps his Market Perform rating and $122 price target on Keurig Dr Pepper but notes that the company's analyst day has positioned it as an "attractive play" amid rising coffee consumption in multiple categories, formats, and channels. Sharma adds that despite his neutral stance on the stock, he is more positive about the company's ability to produce the $600M in cost synergies while also pointing to further margin expansion in the standalone Keurig Green Mountain business.
06/19/18
06/19/18
DOWNGRADE
Target $122

Hold
Dr Pepper downgraded to Hold on limited Keurig potential seen at Stifel
As previously reported, Stifel downgraded Dr Pepper Snapple to Hold from Buy, with analyst Mark Swartzberg telling investors that the more he learns about Keurig Green Mountain, the more he is convinced it has "limited capacity for operating income growth." The analyst, who recently reduced his Dr Pepper forecasts for higher packaging and logistics costs, has also lowered his KGM forecasts after reviewing a series of public filings. He keeps a price target of $122 on Dr Pepper shares to account for his 12-month stub target of $18.25 per share and the $103.75 special cash dividend that is scheduled to be paid.
06/18/18
STFL
06/18/18
DOWNGRADE
STFL
Hold
Dr Pepper Snapple downgraded to Hold from Buy at Stifel
06/19/18
06/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mattel (MAT) downgraded to Neutral from Buy at UBS with analyst Arpine Kocharyan citing the stock's recent 35% appreciation with little change in fundamentals. 2. F5 Networks (FFIV) downgraded to Neutral from Buy at Citi with analyst Jim Suva saying with the stock up 38% year-to-date, the company's price-to-earnings valuation multiple has increased from 14.8 times at the start of the year to 17.8 times. 3. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying the more he learns about Keurig Green Mountain, the more he is convinced it has "limited capacity for operating income growth." 4. Red Hat (RHT) downgraded to Market Perform from Outperform at Raymond James with analyst Michael Turits saying shares are at peak valuation and the company is facing a difficult NTM growth outlook. 5. AT&T (T) downgraded to a Neutral after resuming coverage from Overweight at JPMorgan with analyst Philip Cusick saying he believes reversal of the Time Warner acquisition by the Department of Justice is "very unlikely" and would not be surprised to see AT&T shares "rebound fairly quickly after a period of deal-related flowback." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EXEL Exelixis
$19.55

-0.52 (-2.59%)

05/23/18
RBCM
05/23/18
NO CHANGE
RBCM
Exelixis pullback today a buying opportunity, says RBC Capital
RBC Capital analyst Kennen MacKay attributes the selloff today in shares of Exelixis to April total prescription data from Symphony. The analyst notes, however, that his analysis indicates the Symphony totals for April are well below those of IMS, implying prescription declines from March to April are not seen in IMS data. While the flat month-to-month growth from may be viewed as concerning for Cabo's continued uptake in first-line renal cell carcinoma post approval and launch of competitor Opdivo plus Yervoy in mid-April, March represented an "especially strong month," MacKay tells investors in a research note. He remains a buyer of Exelixis shares on today's weakness.
05/10/18
STFL
05/10/18
NO CHANGE
STFL
Hold
Exelixis pullback may create interesting entry point, says Stifel
After Exelixis (EXEL) and partner Roche (RHHBY) announced the Phase 3 IMblaze370 trial did not achieve statistical-significance on the primary efficacy endpoint evaluating the ability of a combination of a MEK inhibitor and anti-PD-L1 to improve overall survival in patients with microsatellite stable metastatic colorectal cancer, Stifel analyst Stephen Willey said he believes attrition in Exelixis shares might create an interesting entry point. The failure of IMblaze370 removes some of Exelixis' longer-term optionality and he expects topics of RCC growth/competition, label expansion, and longer-term cabozantinib exclusivity to remain core to the story going forward, said Willey who has a Hold rating on the stock. Array BioPharma (ARRY) also has Phase 1/2 development collaborations in place with both Bristol-Myers (BMY) and Merck (MRK) evaluating the MEK/PD-1 hypothesis in earlier-lines of MSS mCRC, noted Willey, who said he would "be opportunistic" on any weakness in its shares. He maintains a Buy rating on Array, which is down 5% in pre-market trading.
05/10/18
PIPR
05/10/18
NO CHANGE
Target $29
PIPR
Overweight
Exelixis price target lowered to $29 from $33 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target on Exelixis (EXEL) to $29 from $33 after partner Roche (RHHBY) reported the Phase 3 IMblaze370 trial in microsatellite stable colorectal cancer patients did not meet its overall survival primary endpoint. However, the data do not impact two ongoing Phase 3 trials of cobimetinib and Tecentriq in BRAF-mutant melanoma, said Tenthoff, who keeps an Overweight rating on Exelixis shares.
05/23/18
RBCM
05/23/18
NO CHANGE
RBCM
Exelixis shares defended at RBC Capital

TODAY'S FREE FLY STORIES

ATTO

Atento

$5.96

0.075 (1.28%)

19:00
11/12/18
11/12
19:00
11/12/18
19:00
Earnings
Atento reports Q3 recurring EPS 25c, consensus 20c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

VKTX

Viking Therapeutics

$11.73

-0.605 (-4.91%)

18:57
11/12/18
11/12
18:57
11/12/18
18:57
Hot Stocks
Viking Therapeutics says VK2809 study achieves primary, secondary endpoints »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

KEX

Kirby

$74.20

-1.83 (-2.41%)

18:31
11/12/18
11/12
18:31
11/12/18
18:31
Hot Stocks
Kirby to acquire CGBM's inland tank barge fleet, terms not disclosed »

Kirby announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HUYA

Huya

$18.50

-0.5 (-2.63%)

, MFIN

Medallion Financial

$6.80

-0.23 (-3.27%)

18:31
11/12/18
11/12
18:31
11/12/18
18:31
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Huya…

HUYA

Huya

$18.50

-0.5 (-2.63%)

MFIN

Medallion Financial

$6.80

-0.23 (-3.27%)

EB

Eventbrite

$30.90

-1.6 (-4.92%)

YRD

Yirendai

$15.47

-1.75 (-10.16%)

KRNT

Kornit Digital

$19.15

-0.88 (-4.39%)

MHLD

Maiden Holdings

$2.40

-1.12 (-31.82%)

SAGE

Sage Therapeutics

$121.50

-9.46 (-7.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 27

    Nov

  • 19

    Dec

OMAB

OMA Airports

$40.18

0.41 (1.03%)

18:18
11/12/18
11/12
18:18
11/12/18
18:18
Hot Stocks
OMA Airports names Ricardo Duenas as new CEO »

The board of OMA approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$2.13

-0.09 (-4.05%)

, IPAS

iPass

$1.14

(0.00%)

18:03
11/12/18
11/12
18:03
11/12/18
18:03
Hot Stocks
Pareteum to acquire iPass in all-stock transaction »

Pareteum (TEUM) and iPass…

TEUM

Pareteum

$2.13

-0.09 (-4.05%)

IPAS

iPass

$1.14

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

NINE

Nine Energy Services

$33.58

-1.6 (-4.55%)

18:01
11/12/18
11/12
18:01
11/12/18
18:01
Earnings
Nine Energy Service reports Q3 EPS 56c, consensus 56c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TEUM

Pareteum

$2.13

-0.09 (-4.05%)

, IPAS

iPass

$1.14

(0.00%)

18:00
11/12/18
11/12
18:00
11/12/18
18:00
Hot Stocks
Breaking Hot Stocks news story on Pareteum, iPass »

Pareteum to acquire iPass…

TEUM

Pareteum

$2.13

-0.09 (-4.05%)

IPAS

iPass

$1.14

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

BMWYY

BMW

$0.00

(0.00%)

17:57
11/12/18
11/12
17:57
11/12/18
17:57
Periodicals
BMW in talks to sell branded credit-card unit, Bloomberg says »

BMW is held talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$189.37

-16.25 (-7.90%)

17:54
11/12/18
11/12
17:54
11/12/18
17:54
Hot Stocks
Nvidia reports record adoption of new Turing T4 GPU »

Nvidia announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

GLD

SPDR Gold Trust

$113.66

-0.82 (-0.72%)

17:51
11/12/18
11/12
17:51
11/12/18
17:51
Hot Stocks
SPDR Gold Trust holdings rise to 762.00MT from 755.23MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$331.15

-19.54 (-5.57%)

17:45
11/12/18
11/12
17:45
11/12/18
17:45
Periodicals
Tesla legal executive with regulatory experience leaving, Bloomberg says »

Amid a recent fraud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 13

    Dec

HUYA

Huya

$18.50

-0.5 (-2.63%)

17:34
11/12/18
11/12
17:34
11/12/18
17:34
Hot Stocks
Huya reports Q3 average mobile MAUs 49.4M, up 28.2% from last year »

Q3 Average MAUs reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

VLKAY

Volkswagen

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

17:34
11/12/18
11/12
17:34
11/12/18
17:34
Periodicals
Trump close to auto tariffs in a move that may have 'massive' fallout, BI says »

According to Business…

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$115.48

-1.83 (-1.56%)

F

Ford

$9.49

0.11 (1.17%)

HMC

Honda

$28.16

-0.34 (-1.19%)

GM

General Motors

$35.71

0.01 (0.03%)

FCAU

Fiat Chrysler

$15.78

-0.48 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 13

    Dec

MPVD

Mountain Province Diamonds

$1.42

-0.03 (-2.07%)

17:32
11/12/18
11/12
17:32
11/12/18
17:32
Earnings
Mountain Province Diamonds reports Q3 EPS 8c, one estimate 6c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HUYA

Huya

$18.50

-0.5 (-2.63%)

17:32
11/12/18
11/12
17:32
11/12/18
17:32
Earnings
Breaking Earnings news story on Huya »

Huya sees Q4 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

YY

YY

$61.39

-3.34 (-5.16%)

17:32
11/12/18
11/12
17:32
11/12/18
17:32
Earnings
Breaking Earnings news story on YY »

YY sees Q4 revenue growtn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$18.50

-0.5 (-2.63%)

17:31
11/12/18
11/12
17:31
11/12/18
17:31
Earnings
Huya reports Q3 EPS 4c, consensus 4c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

YY

YY

$61.39

-3.34 (-5.16%)

17:31
11/12/18
11/12
17:31
11/12/18
17:31
Earnings
YY reports Q3 adjusted income per ADS $1.76, consensus $1.67 »

Reports Q3 revenue $597M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$117.47

-2.065 (-1.73%)

, XOM

Exxon Mobil

$79.87

-1.01 (-1.25%)

17:28
11/12/18
11/12
17:28
11/12/18
17:28
Periodicals
Breaking Periodicals news story on Chevron, Exxon Mobil »

Exxon Mobil and Chevron…

CVX

Chevron

$117.47

-2.065 (-1.73%)

XOM

Exxon Mobil

$79.87

-1.01 (-1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 26

    Nov

ESS

Essex Property Trust

$254.54

0.59 (0.23%)

17:26
11/12/18
11/12
17:26
11/12/18
17:26
Hot Stocks
Essex Property Trust sees no significant damage to CA portfolio from fires »

Essex Property Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROAN

Roan Resources

$15.90

(0.00%)

17:25
11/12/18
11/12
17:25
11/12/18
17:25
Hot Stocks
Roan Resources sees Q4 production 52-56 MBoe/d »

The Company is projecting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROAN

Roan Resources

$15.90

(0.00%)

17:24
11/12/18
11/12
17:24
11/12/18
17:24
Hot Stocks
Roan Resources reports Q3 total production up 30% to 46.5 MBoe/d »

Liquids production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROAN

Roan Resources

$15.90

(0.00%)

17:23
11/12/18
11/12
17:23
11/12/18
17:23
Earnings
Roan Resources reports Q3 adjusted EPS 21c, consensus 24c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.66

-1.44 (-2.99%)

17:19
11/12/18
11/12
17:19
11/12/18
17:19
Hot Stocks
Intel accelerates launch of multimode modem to support 5G rollouts »

Intel announced the Intel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 26

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.